首页 > 最新文献

Annals of clinical and laboratory science最新文献

英文 中文
Differences in 1HNMR Based Metabolomic Patterns of Malignant and Benign Pleural Effusions. 恶性和良性胸腔积液基于 1HNMR 的代谢组学模式的差异。
IF 0.8 4区 医学 Q3 Medicine Pub Date : 2024-03-01
Tongshun Xie, Qing Wang, Jie Gao, Kanheng He, Jiangqing Yu

Objective: Malignant pleural effusion (MPE) is a common complication of lung cancer with poor prognosis. Benign pleural effusion (BPE), such as tuberculous and pneumonic pleural effusion, usually has a good prognosis. Differential diagnosis between MPE and BPE remains a clinical challenge.

Methods: 52 MPE, 93 BPE, and their corresponding serum samples were analyzed by hydrogen nuclear magnetic resonance (1HNMR) based metabolomics.

Results: The 1HNMR study showed that some amino acids and betaine in MPE are significantly altered in pleural effusion and serum compared to BPE patients. Levels of serum glucose and glutamine have strong positive correlation with those in pleural effusion (r>0.6) for MPE patients. The area under the receiver operating characteristic curve (AUROC) values of metabolites in pleural effusion or serum were less than 0.805 in differentiating MPE from BPE. Improved an AUROC value of 0.901 was observed using pleural effusion-serum ratios of glutamic acid in differentiating MPE from BPE, which was further validated by 15 double-blind samples.

Conclusions: Compared with BPE patients, amino acids and betaine in MPE are significantly altered in pleural effusion and serum. Pleural effusion-serum ratio of glutamic acid may contribute to the rapid diagnosis of MPE from BPE by 1HNMR analysis.

目的:恶性胸腔积液(MPE)是肺癌的常见并发症,预后较差:恶性胸腔积液(MPE)是肺癌的常见并发症,预后较差。良性胸腔积液(BPE),如结核性和肺炎性胸腔积液,通常预后良好。方法:采用基于氢核磁共振(1HNMR)的代谢组学方法对 52 例 MPE、93 例 BPE 及其相应的血清样本进行分析:结果:1HNMR 研究显示,与 BPE 患者相比,MPE 患者胸腔积液和血清中的某些氨基酸和甜菜碱发生了显著变化。MPE 患者的血清葡萄糖和谷氨酰胺水平与胸腔积液中的葡萄糖和谷氨酰胺水平有很强的正相关性(r>0.6)。在区分 MPE 和 BPE 时,胸腔积液或血清中代谢物的接收者操作特征曲线下面积(AUROC)值小于 0.805。使用胸腔积液与血清中谷氨酸的比值来区分 MPE 和 BPE,其 AUROC 值为 0.901:与 BPE 患者相比,MPE 患者胸腔积液和血清中的氨基酸和甜菜碱发生了显著变化。胸腔积液与血清中谷氨酸的比值有助于通过 1HNMR 分析快速诊断 MPE 与 BPE。
{"title":"Differences in <sup>1</sup>HNMR Based Metabolomic Patterns of Malignant and Benign Pleural Effusions.","authors":"Tongshun Xie, Qing Wang, Jie Gao, Kanheng He, Jiangqing Yu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Malignant pleural effusion (MPE) is a common complication of lung cancer with poor prognosis. Benign pleural effusion (BPE), such as tuberculous and pneumonic pleural effusion, usually has a good prognosis. Differential diagnosis between MPE and BPE remains a clinical challenge.</p><p><strong>Methods: </strong>52 MPE, 93 BPE, and their corresponding serum samples were analyzed by hydrogen nuclear magnetic resonance (<sup>1</sup>HNMR) based metabolomics.</p><p><strong>Results: </strong>The <sup>1</sup>HNMR study showed that some amino acids and betaine in MPE are significantly altered in pleural effusion and serum compared to BPE patients. Levels of serum glucose and glutamine have strong positive correlation with those in pleural effusion (r>0.6) for MPE patients. The area under the receiver operating characteristic curve (AUROC) values of metabolites in pleural effusion or serum were less than 0.805 in differentiating MPE from BPE. Improved an AUROC value of 0.901 was observed using pleural effusion-serum ratios of glutamic acid in differentiating MPE from BPE, which was further validated by 15 double-blind samples.</p><p><strong>Conclusions: </strong>Compared with BPE patients, amino acids and betaine in MPE are significantly altered in pleural effusion and serum. Pleural effusion-serum ratio of glutamic acid may contribute to the rapid diagnosis of MPE from BPE by <sup>1</sup>HNMR analysis.</p>","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of Staining Intensity in Ki-67 Proliferation Index in Meningiomas, and a Critical Review of the Literature on Proliferation Index Assessment. 脑膜瘤 Ki-67 增殖指数染色强度的意义,以及关于增殖指数评估的文献综述。
IF 0.8 4区 医学 Q3 Medicine Pub Date : 2024-03-01
Olivia C Brasher, James S Nix, Murat Gokden

Objective: Meningioma is the most common primary adult intracranial neoplasm, and proliferation indices (PI) rise with increasing grade from WHO CNS grade 1 to 3. Ki-67 immunohistochemistry (IHC) poses a variety of technical and interpretative challenges. Here, we specifically investigated the staining intensity and its effect on interpretation and final diagnosis.

Methods: 124 high and low-grade meningiomas of various grades were blindly evaluated using different counting strategies (CS) based on the staining intensity of the nuclei as darkest (CS1), darkest+intermediate (CS2), and any staining (CS3) in hot-spots (HS) and in the context of overall proliferative activity (OPA).

Result: CSs in HS, OPA, and their average results were significantly different between low-grade and high-grade groups. PI obtained using CS3 yielded results that matched best with values expected for the corresponding WHO grade. CS had a profound impact on whether a LG meningioma would be diagnosed as one with a "high proliferation index."

Conclusion: A large body of work exists on the counting methods, clinically significant cut-off values, and inter- and intra-observer variability for Ki-67 PI interpretation. We show that Ki-67 IHC staining intensity, which to our knowledge has not been previously systematically investigated, can have a significant effect on PI interpretation in settings that influence diagnostic and clinical management decisions.

目的:脑膜瘤是成人颅内最常见的原发性肿瘤,其增殖指数(PI)随WHO CNS 1级至3级的级别升高而升高。Ki-67免疫组化(IHC)带来了各种技术和解释上的挑战。方法:采用不同的计数策略(CS)对124个不同级别的高级别和低级别脑膜瘤进行盲法评估,计数策略的依据是热点(HS)中最暗(CS1)、最暗+中间(CS2)和任何染色(CS3)的核染色强度,以及整体增殖活性(OPA):结果:HS、OPA 中的 CSs 及其平均结果在低级别组和高级别组之间存在显著差异。使用 CS3 得出的 PI 结果与相应的 WHO 分级的预期值最为吻合。CS对LG脑膜瘤是否被诊断为 "高增殖指数 "有深远影响:关于Ki-67 PI的计数方法、具有临床意义的临界值以及观察者之间和观察者内部的差异性,目前已有大量研究。我们的研究表明,据我们所知,Ki-67 IHC染色强度以前从未进行过系统的研究,但在影响诊断和临床管理决策的情况下,Ki-67 IHC染色强度会对PI判读产生重大影响。
{"title":"Significance of Staining Intensity in Ki-67 Proliferation Index in Meningiomas, and a Critical Review of the Literature on Proliferation Index Assessment.","authors":"Olivia C Brasher, James S Nix, Murat Gokden","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Meningioma is the most common primary adult intracranial neoplasm, and proliferation indices (PI) rise with increasing grade from WHO CNS grade 1 to 3. Ki-67 immunohistochemistry (IHC) poses a variety of technical and interpretative challenges. Here, we specifically investigated the staining intensity and its effect on interpretation and final diagnosis.</p><p><strong>Methods: </strong>124 high and low-grade meningiomas of various grades were blindly evaluated using different counting strategies (CS) based on the staining intensity of the nuclei as darkest (CS1), darkest+intermediate (CS2), and any staining (CS3) in hot-spots (HS) and in the context of overall proliferative activity (OPA).</p><p><strong>Result: </strong>CSs in HS, OPA, and their average results were significantly different between low-grade and high-grade groups. PI obtained using CS3 yielded results that matched best with values expected for the corresponding WHO grade. CS had a profound impact on whether a LG meningioma would be diagnosed as one with a \"high proliferation index.\"</p><p><strong>Conclusion: </strong>A large body of work exists on the counting methods, clinically significant cut-off values, and inter- and intra-observer variability for Ki-67 PI interpretation. We show that Ki-67 IHC staining intensity, which to our knowledge has not been previously systematically investigated, can have a significant effect on PI interpretation in settings that influence diagnostic and clinical management decisions.</p>","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141156850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of YD MolecuTech Real HPV Assay in Comparison with Roche Cobas HPV Assay and BD Onclarity HPV Assay for Detection of HPV Infection. 评估 YD MolecuTech Real HPV 检测法与罗氏 Cobas HPV 检测法和 BD Onclarity HPV 检测法在检测 HPV 感染方面的比较。
IF 0.8 4区 医学 Q3 Medicine Pub Date : 2024-03-01
Chang-Hun Park, Chang-Woon Kim, Hyoun Wook Lee, Min-Jung Kwon

Objective: Human papillomavirus (HPV) is a double-stranded DNA virus that belongs to the papillomavirus family. High-risk (HR) genotypes of HPV are associated with cervical cancer. The combination of molecular HPV testing and cytology results in an increased detection of high-grade cervical lesions. This study compares the performance of a newly developed MolecuTech Real HPV 16/18/HR assay to that of the cobas HPV assay and Onclarity HPV Assay in Korea.

Methods: A SurePath liquid-based cytology device (BD diagnostics, NC, USA) was used to prospectively collect cervical swab specimens. Onclarity HPV Assay (Onclarity; BD diagnostics), Cobas 4800 HPV Test (Cobas; Roche, Rotkreuz, Switzerland), and MolecuTech Real HPV 16/18/HR (MolecuTech; YD, Yongin, Korea) were performed to detect HPV genotypes.

Results: Of the 438 cervical specimens, 13.7% showed the HR-HPV genotype. The concordance rates between Onclarity and MolecuTech, cobas and MolecuTech, and Onclarity and Cobas were 94.9% (kappa=0.754), 95.7% (kappa=0.768), and 95.5% (kappa=0.791), respectively. Moreover, no statistically significant differences in HPV genotyping results were observed in the cytology-positive specimens.

Conclusions: The MolecuTech Real HPV 16/18/HR assay showed good agreement in the detection of HR HPV genotypes, and similar analytical performance for the detection of HR HPV genotypes in samples with abnormal cytological findings.

目的:人类乳头瘤病毒(HPV)是一种双链 DNA 病毒,属于乳头瘤病毒家族。HPV的高危(HR)基因型与宫颈癌有关。分子 HPV 检测与细胞学检查相结合,可提高高级别宫颈病变的检出率。本研究比较了韩国新开发的 MolecuTech Real HPV 16/18/HR 检测法与 cobas HPV 检测法和 Onclarity HPV 检测法的性能:方法: 使用 SurePath 液基细胞学设备(美国北卡罗来纳州 BD 诊断公司)前瞻性地收集宫颈拭子标本。方法:使用 SurePath 液基细胞学设备(BD 诊断公司,美国北卡罗来纳州)前瞻性地收集宫颈拭子标本,并使用 Onclarity HPV Assay(Onclarity;BD 诊断公司)、Cobas 4800 HPV Test(Cobas;罗氏,瑞士罗特克鲁兹)和 MolecuTech Real HPV 16/18/HR(MolecuTech;YD,韩国龙仁市)检测 HPV 基因型:结果:在 438 份宫颈标本中,13.7% 显示 HR-HPV 基因型。Onclarity与MolecuTech、cobas与MolecuTech、Onclarity与Cobas之间的吻合率分别为94.9%(kappa=0.754)、95.7%(kappa=0.768)和95.5%(kappa=0.791)。此外,在细胞学阳性标本中,HPV 基因分型结果无统计学差异:结论:MolecuTech Real HPV 16/18/HR检测方法在检测HR HPV基因型方面表现出良好的一致性,在检测细胞学结果异常样本中的HR HPV基因型方面具有相似的分析性能。
{"title":"Evaluation of YD MolecuTech Real HPV Assay in Comparison with Roche Cobas HPV Assay and BD Onclarity HPV Assay for Detection of HPV Infection.","authors":"Chang-Hun Park, Chang-Woon Kim, Hyoun Wook Lee, Min-Jung Kwon","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Human papillomavirus (HPV) is a double-stranded DNA virus that belongs to the papillomavirus family. High-risk (HR) genotypes of HPV are associated with cervical cancer. The combination of molecular HPV testing and cytology results in an increased detection of high-grade cervical lesions. This study compares the performance of a newly developed MolecuTech Real HPV 16/18/HR assay to that of the cobas HPV assay and Onclarity HPV Assay in Korea.</p><p><strong>Methods: </strong>A SurePath liquid-based cytology device (BD diagnostics, NC, USA) was used to prospectively collect cervical swab specimens. Onclarity HPV Assay (Onclarity; BD diagnostics), Cobas 4800 HPV Test (Cobas; Roche, Rotkreuz, Switzerland), and MolecuTech Real HPV 16/18/HR (MolecuTech; YD, Yongin, Korea) were performed to detect HPV genotypes.</p><p><strong>Results: </strong>Of the 438 cervical specimens, 13.7% showed the HR-HPV genotype. The concordance rates between Onclarity and MolecuTech, cobas and MolecuTech, and Onclarity and Cobas were 94.9% (kappa=0.754), 95.7% (kappa=0.768), and 95.5% (kappa=0.791), respectively. Moreover, no statistically significant differences in HPV genotyping results were observed in the cytology-positive specimens.</p><p><strong>Conclusions: </strong>The MolecuTech Real HPV 16/18/HR assay showed good agreement in the detection of HR HPV genotypes, and similar analytical performance for the detection of HR HPV genotypes in samples with abnormal cytological findings.</p>","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: Utility of PLASMIC Score, Bentley Score, and Laboratory Parameters in Predicting Severe ADAMTS13 Deficiency in Patients with Suspected Thrombotic Thrombocytopenic Purpura. 致编辑的信:PLASMIC 评分、宾利评分和实验室参数在预测疑似血栓性血小板减少性紫癜患者严重 ADAMTS13 缺乏症中的实用性。
IF 0.8 4区 医学 Q3 Medicine Pub Date : 2024-03-01
Yonggoo Kim, Ari Ahn, Jong-Mi Lee, Myungshin Kim, Hey Kyung Lee, Hyunjung Kim
{"title":"<i>Letter to the Editor:</i> Utility of PLASMIC Score, Bentley Score, and Laboratory Parameters in Predicting Severe ADAMTS13 Deficiency in Patients with Suspected Thrombotic Thrombocytopenic Purpura.","authors":"Yonggoo Kim, Ari Ahn, Jong-Mi Lee, Myungshin Kim, Hey Kyung Lee, Hyunjung Kim","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141157956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep Learning Provides Rapid Screen for Breast Cancer Metastasis with Sentinel Lymph Nodes. 深度学习利用前哨淋巴结快速筛查乳腺癌转移
IF 0.8 4区 医学 Q3 Medicine Pub Date : 2024-01-04
Kareem Allam, Xiaohong Iris Wang, Songlin Zhang, Jianmin Ding, Kevin Chiu, Karan Saluja, Amer Wahed, Hongxia Sun, Andy N D Nguyen

Objective: Deep learning has been shown to be useful in detecting breast cancer metastases by analyzing whole slide images (WSI) of sentinel lymph nodes; however, it requires extensive analysis of all the lymph node slides. Our deep learning study attempts to provide a rapid screen for metastasis by analyzing only a small set of image patches to detect changes in tumor environment.

Methods: We designed a convolutional neural network to build a diagnostic model for metastasis detection. We obtained WSIs of Hematoxylin and Eosin-stained slides from 34 cases with equal distribution in positive/negative categories. Two WSIs were selected from each case for a total of 69 WSIs. From each WSI, 40 image patches (100x100 pixels) were obtained to yield 2720 image patches, from which 2160 (79%) were used for training, 240 (9%) for validation, and 320 (12%) for testing. Interobserver variation was also examined among 3 users.

Results: The test results showed excellent diagnostic results: accuracy (91.15%), sensitivity (77.92%), and specificity (92.09%). No significant variation in results was observed among the 3 observers.

Conclusion: This preliminary study provided a proof of concept for conducting a rapid screen for metastasis rather than an exhaustive search for tumors in all fields of all sentinel lymph nodes.

目的:通过分析前哨淋巴结的全切片图像(WSI),深度学习已被证明可用于检测乳腺癌转移;然而,这需要对所有淋巴结切片进行大量分析。我们的深度学习研究试图通过分析一小部分图像片段来检测肿瘤环境的变化,从而快速筛查转移:方法:我们设计了一个卷积神经网络来建立转移检测诊断模型。我们从 34 个病例的血栓素和伊红染色切片中获得了 WSIs,这些 WSIs 在阳性/阴性类别中分布均等。每个病例选取两个 WSI,共计 69 个 WSI。从每个 WSI 中获取 40 个图像片段(100x100 像素),共得到 2720 个图像片段,其中 2160 个(79%)用于训练,240 个(9%)用于验证,320 个(12%)用于测试。此外,还对 3 名用户的观察者之间的差异进行了研究:测试结果显示了极佳的诊断效果:准确率(91.15%)、灵敏度(77.92%)和特异性(92.09%)。结论:这项初步研究证明了这一概念:这项初步研究为快速筛查肿瘤转移提供了概念验证,而不是在所有前哨淋巴结的所有区域进行详尽的肿瘤搜索。
{"title":"Deep Learning Provides Rapid Screen for Breast Cancer Metastasis with Sentinel Lymph Nodes.","authors":"Kareem Allam, Xiaohong Iris Wang, Songlin Zhang, Jianmin Ding, Kevin Chiu, Karan Saluja, Amer Wahed, Hongxia Sun, Andy N D Nguyen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Deep learning has been shown to be useful in detecting breast cancer metastases by analyzing whole slide images (WSI) of sentinel lymph nodes; however, it requires extensive analysis of all the lymph node slides. Our deep learning study attempts to provide a rapid screen for metastasis by analyzing only a small set of image patches to detect changes in tumor environment.</p><p><strong>Methods: </strong>We designed a convolutional neural network to build a diagnostic model for metastasis detection. We obtained WSIs of Hematoxylin and Eosin-stained slides from 34 cases with equal distribution in positive/negative categories. Two WSIs were selected from each case for a total of 69 WSIs. From each WSI, 40 image patches (100x100 pixels) were obtained to yield 2720 image patches, from which 2160 (79%) were used for training, 240 (9%) for validation, and 320 (12%) for testing. Interobserver variation was also examined among 3 users.</p><p><strong>Results: </strong>The test results showed excellent diagnostic results: accuracy (91.15%), sensitivity (77.92%), and specificity (92.09%). No significant variation in results was observed among the 3 observers.</p><p><strong>Conclusion: </strong>This preliminary study provided a proof of concept for conducting a rapid screen for metastasis rather than an exhaustive search for tumors in all fields of all sentinel lymph nodes.</p>","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139105796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MicroRNA-193a Promotes Apoptosis in Retinal Neuronal Cells in Early-Stage Diabetic (DM) Rat via Wilms' Tumor Gene 1. MicroRNA-193a 通过 Wilms' Tumor Gene 1 促进早期糖尿病 (DM) 大鼠视网膜神经元细胞的凋亡
IF 0.8 4区 医学 Q3 Medicine Pub Date : 2024-01-04
Juan Yu, Kehai Che, Chong Gao, Xuemei Pu, Lijun Ren

Objective: This study aimed to investigate the role and mechanism of microRNA (miR)-193a in promoting apoptosis of retinal neuronal cells in early diabetic (DM) rats.

Methods: Seventy-two male SD-grade rats were selected to establish a DM model by intraperitoneal injection of streptozotocin (STZ), and randomly divided into a control group (blank control group), a DM group (diabetic model group), a DM+miR-NC inhibitor group (miR-193a inhibition negative control group), a DM+miR-193a inhibitor group (miR-193a inhibitor group), DM+miR-NC mimic group (miR-193a overexpression negative control group), DM+miR-193a mimic group (miR-193a overexpression group), with12 rats in each group.

Results: The miR-193a expression, apoptosis rate, and Bax, Caspase3, and Caspase9 protein expression levels were elevated, and Bcl-2 protein expression was decreased in the retinal tissues of DM rats and high glucose-induced rat retinal neuronal cells, while miR-193a inhibitors reversed these processes. These dual luciferase reporter assay showed that WT1CDS, and WT1Mut were lower in the miR-193a group than in the miR-NC group (P<0.05); WT1 protein expression was reduced in the retinal tissues of DM rat and high glucose-induced rat retinal neuronal cells, and miR-193a inhibitors increased WT1 protein expression. Compared with cells co-transfected with miR-193a and WT1vector, miR-193a and WT1 cotransfection inhibited high glucose-induced apoptosis in retinal neuronal cells and regulated apoptotic protein expression. miR-193a was highly expressed and WT1 was lowly expressed in retinal tissues of DM rats and high glucose-induced rat retinal neuronal cells.

Conclusion: miR-193a could inhibit early retinal neuronal cell apoptosis in DM rats by targeting and negatively regulating WT1 expression.

研究目的本研究旨在探讨microRNA(miR)-193a在促进早期糖尿病(DM)大鼠视网膜神经细胞凋亡中的作用和机制:方法:选取72只雄性SD级大鼠腹腔注射链脲佐菌素(STZ)建立DM模型,随机分为对照组(空白对照组)、DM组(糖尿病模型组)和miR-193a抑制组(DM+miR-NC抑制组)、DM+miR-NC抑制剂组(miR-193a抑制阴性对照组)、DM+miR-193a抑制剂组(miR-193a抑制剂组)、DM+miR-NC模拟组(miR-193a过表达阴性对照组)、DM+miR-193a模拟组(miR-193a过表达组),每组12只。结果在DM大鼠视网膜组织和高糖诱导的大鼠视网膜神经细胞中,miR-193a表达、凋亡率、Bax、Caspase3和Caspase9蛋白表达水平升高,Bcl-2蛋白表达降低,而miR-193a抑制剂可逆转这些过程。这些双荧光素酶报告实验表明,miR-193a组的WT1CDS和WT1Mut低于miR-NC组(结论:miR-193a可通过靶向和负调控WT1的表达来抑制DM大鼠早期视网膜神经细胞凋亡。
{"title":"MicroRNA-193a Promotes Apoptosis in Retinal Neuronal Cells in Early-Stage Diabetic (DM) Rat via Wilms' Tumor Gene 1.","authors":"Juan Yu, Kehai Che, Chong Gao, Xuemei Pu, Lijun Ren","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the role and mechanism of microRNA (miR)-193a in promoting apoptosis of retinal neuronal cells in early diabetic (DM) rats.</p><p><strong>Methods: </strong>Seventy-two male SD-grade rats were selected to establish a DM model by intraperitoneal injection of streptozotocin (STZ), and randomly divided into a control group (blank control group), a DM group (diabetic model group), a DM+miR-NC inhibitor group (miR-193a inhibition negative control group), a DM+miR-193a inhibitor group (miR-193a inhibitor group), DM+miR-NC mimic group (miR-193a overexpression negative control group), DM+miR-193a mimic group (miR-193a overexpression group), with12 rats in each group.</p><p><strong>Results: </strong>The miR-193a expression, apoptosis rate, and Bax, Caspase3, and Caspase9 protein expression levels were elevated, and Bcl-2 protein expression was decreased in the retinal tissues of DM rats and high glucose-induced rat retinal neuronal cells, while miR-193a inhibitors reversed these processes. These dual luciferase reporter assay showed that WT1CDS, and WT1Mut were lower in the miR-193a group than in the miR-NC group (<i>P</i><0.05); WT1 protein expression was reduced in the retinal tissues of DM rat and high glucose-induced rat retinal neuronal cells, and miR-193a inhibitors increased WT1 protein expression. Compared with cells co-transfected with miR-193a and WT1vector, miR-193a and WT1 cotransfection inhibited high glucose-induced apoptosis in retinal neuronal cells and regulated apoptotic protein expression. miR-193a was highly expressed and WT1 was lowly expressed in retinal tissues of DM rats and high glucose-induced rat retinal neuronal cells.</p><p><strong>Conclusion: </strong>miR-193a could inhibit early retinal neuronal cell apoptosis in DM rats by targeting and negatively regulating WT1 expression.</p>","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139105798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolution of SARS-CoV-2 Viral Mutations in Individuals with Prolonged Infections. SARS-CoV-2 病毒变异在长期感染者中的演变。
IF 0.8 4区 医学 Q3 Medicine Pub Date : 2024-01-04
Luna Jiang-Qin, Kevin Weitemier, Guang Fan, Xuan Qin

Objective: The world has been faced with the repeat rise of SARS-CoV-2 variants since late 2020, including Alpha, Beta, Gamma, Delta, and the latest simultaneous emergence of far-flung spawn of Omicron sub-lineages in different parts of the globe. This has brought us the challenge of determining what factor(s) have been the selective force behind these immune evasive and therapy resistant mutations. It is very possible that such variants evolved in limited host individuals with prolonged infections, or from a localized community of patients.

Methods: This study surveys the GISAID time capsule of mutations found in viral genomes from patients with prolonged same lineage viral infections. We analyzed 288 SARS-CoV-2 genomes representing 113 patients who had same lineage viral genomes in two or more samples stored in GISAID.

Results: Of these, thirty-five (30.9%) of the 113 patients developed mutations during their infections. Samples from patients whose viral genomes showed nucleotide changes(s) (n=35) versus those that showed no change (n=78) had a statistically significant difference (p=2.121x10-4) in duration of infection by a median of 13 days (range 0-109 days) versus 6 days (range 0-72 days), respectively. Five highly recognizable variant-defining mutations with immune evasion properties were identified in 5 cases infected by the B.1 lineages in late 2020 and early 2021.

Conclusion: This suggests the duration of infection is a contributing factor that gives rise to mutations, but not the sole factor, and individual host conditions may play a critical role in driving viral evolution.

目的:自 2020 年末以来,SARS-CoV-2 的变种不断出现,包括 Alpha、Beta、Gamma、Delta 和最近在全球不同地区同时出现的 Omicron 亚系。这给我们带来了一个挑战,即确定这些免疫逃避和抗药性变异背后的选择性因素是什么。这些变异很有可能是在有限的宿主个体长期感染的情况下进化而来的,也有可能是在局部地区的患者群体中进化而来的:本研究调查了 GISAID 时间胶囊中在长期同系病毒感染患者的病毒基因组中发现的变异。我们分析了 288 个 SARS-CoV-2 基因组,这些基因组代表了在 GISAID 中储存的两个或更多样本中具有同系病毒基因组的 113 名患者:其中,113 名患者中有 35 人(30.9%)在感染期间发生了变异。病毒基因组出现核苷酸变化的患者样本(n=35)与未出现核苷酸变化的患者样本(n=78)在感染持续时间上存在显著差异(p=2.121x10-4),中位数分别为13天(0-109天)和6天(0-72天)。在2020年底和2021年初感染B.1系的5个病例中,发现了5个具有免疫逃避特性的高度可识别变异定义突变:结论:这表明感染持续时间是导致变异的一个因素,但不是唯一因素,宿主的个体条件可能在驱动病毒进化方面起着关键作用。
{"title":"Evolution of SARS-CoV-2 Viral Mutations in Individuals with Prolonged Infections.","authors":"Luna Jiang-Qin, Kevin Weitemier, Guang Fan, Xuan Qin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>The world has been faced with the repeat rise of SARS-CoV-2 variants since late 2020, including Alpha, Beta, Gamma, Delta, and the latest simultaneous emergence of far-flung spawn of Omicron sub-lineages in different parts of the globe. This has brought us the challenge of determining what factor(s) have been the selective force behind these immune evasive and therapy resistant mutations. It is very possible that such variants evolved in limited host individuals with prolonged infections, or from a localized community of patients.</p><p><strong>Methods: </strong>This study surveys the GISAID time capsule of mutations found in viral genomes from patients with prolonged same lineage viral infections. We analyzed 288 SARS-CoV-2 genomes representing 113 patients who had same lineage viral genomes in two or more samples stored in GISAID.</p><p><strong>Results: </strong>Of these, thirty-five (30.9%) of the 113 patients developed mutations during their infections. Samples from patients whose viral genomes showed nucleotide changes(s) (n=35) versus those that showed no change (n=78) had a statistically significant difference (<i>p</i>=2.121x10<sup>-4</sup>) in duration of infection by a median of 13 days (range 0-109 days) versus 6 days (range 0-72 days), respectively. Five highly recognizable variant-defining mutations with immune evasion properties were identified in 5 cases infected by the B.1 lineages in late 2020 and early 2021.</p><p><strong>Conclusion: </strong>This suggests the duration of infection is a contributing factor that gives rise to mutations, but not the sole factor, and individual host conditions may play a critical role in driving viral evolution.</p>","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139105797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Monocyte-to-Lymphocyte Ratio on the 6th Day Postburn Is Associated with Clinical Outcome of Severe Burns. 烧伤后第 6 天的单核细胞与淋巴细胞比率与严重烧伤的临床结果有关。
IF 0.8 4区 医学 Q3 Medicine Pub Date : 2024-01-01
Lizhu Zhi, Yilan Xia, Fang Jin, Xiaojie He, Xingang Wang, Xuanliang Pan

Objective: As an immune/inflammatory indicator, the application of monocyte-lymphocyte ratio (MLR) in the treatment of severe burns is lacking. The aim of this study was to investigate the dynamic changes of the MLR value in the early stage of severe burns and its clinical value.

Methods: This is a 5-year retrospective cohort study involving 100 patients with severe burns (II-III degree and total body surface area (TBSA) >50%), in which the lymphocyte count, monocyte count, MLR value, C-reactive protein (CRP), creatinine (Scr), and capillary leakage index (CLI) were evaluated soon after injury, and 30-day mortality rates were investigated.

Results: The MLR values in non-survivors with severe burns were higher than those in survivors in the first two days after injury, while the values on the 3rd, 5th, 6th and 7th day after injury were lower than those in survivors. The differences between the 6th and 7th days after injury were statistically significant. According to the results of logistic and Cox regression analysis, the MLR values on the 6th day after injury were independent predictors of mortality, and the area under the ROC curve of the 6th day MLR for severe burn-delayed death prediction was 0.658 (95% confidence interval, 0.541-0.774), and the optimal cut-off value was 0.991. The 30-day mortality rates differed significantly between the MLR6 ≥0.991 group and the MLR6≤0.991 group (P<0.05). Within one week after injury, the MLR values were negatively correlated with Scr, CRP and CLI levels for severe burns.

Conclusions: Our results revealed the dynamic characteristics of the MLR value in the early stage of severe burns, reflecting important changes in the immune/inflammatory related stress response soon after injury, low MLR level was associated with the worsening of disease condition.

目的:单核淋巴细胞比值(MLR)作为一项免疫/炎症指标,在重度烧伤治疗中的应用尚属空白。本研究旨在探讨重度烧伤早期 MLR 值的动态变化及其临床价值:这是一项为期 5 年的回顾性队列研究,涉及 100 例重度烧伤患者(II-III 度,总体表面积(TBSA)大于 50%),研究人员对伤后不久的淋巴细胞计数、单核细胞计数、MLR 值、C 反应蛋白(CRP)、肌酐(Scr)和毛细血管渗漏指数(CLI)进行了评估,并调查了 30 天死亡率:结果:非幸存者重度烧伤患者的 MLR 值在伤后头两天高于幸存者,而在伤后第 3、5、6 和 7 天则低于幸存者。伤后第 6 天和第 7 天之间的差异具有统计学意义。根据逻辑回归和 Cox 回归分析结果,伤后第 6 天的 MLR 值是死亡率的独立预测因子,第 6 天 MLR 预测严重烧伤延迟死亡的 ROC 曲线下面积为 0.658(95% 置信区间,0.541-0.774),最佳临界值为 0.991。MLR6≥0.991组与MLR6≤0.991组的30天死亡率差异显著(PConclusions:我们的研究结果揭示了重度烧伤早期 MLR 值的动态特征,反映了伤后不久免疫/炎症相关应激反应的重要变化,低 MLR 水平与病情恶化相关。
{"title":"The Monocyte-to-Lymphocyte Ratio on the 6<sup>th</sup> Day Postburn Is Associated with Clinical Outcome of Severe Burns.","authors":"Lizhu Zhi, Yilan Xia, Fang Jin, Xiaojie He, Xingang Wang, Xuanliang Pan","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>As an immune/inflammatory indicator, the application of monocyte-lymphocyte ratio (MLR) in the treatment of severe burns is lacking. The aim of this study was to investigate the dynamic changes of the MLR value in the early stage of severe burns and its clinical value.</p><p><strong>Methods: </strong>This is a 5-year retrospective cohort study involving 100 patients with severe burns (II-III degree and total body surface area (TBSA) >50%), in which the lymphocyte count, monocyte count, MLR value, C-reactive protein (CRP), creatinine (Scr), and capillary leakage index (CLI) were evaluated soon after injury, and 30-day mortality rates were investigated.</p><p><strong>Results: </strong>The MLR values in non-survivors with severe burns were higher than those in survivors in the first two days after injury, while the values on the 3<sup>rd</sup>, 5<sup>th</sup>, 6<sup>th</sup> and 7<sup>th</sup> day after injury were lower than those in survivors. The differences between the 6<sup>th</sup> and 7<sup>th</sup> days after injury were statistically significant. According to the results of logistic and Cox regression analysis, the MLR values on the 6<sup>th</sup> day after injury were independent predictors of mortality, and the area under the ROC curve of the 6<sup>th</sup> day MLR for severe burn-delayed death prediction was 0.658 (95% confidence interval, 0.541-0.774), and the optimal cut-off value was 0.991. The 30-day mortality rates differed significantly between the MLR6 ≥0.991 group and the MLR6≤0.991 group (<i>P</i><0.05). Within one week after injury, the MLR values were negatively correlated with Scr, CRP and CLI levels for severe burns.</p><p><strong>Conclusions: </strong>Our results revealed the dynamic characteristics of the MLR value in the early stage of severe burns, reflecting important changes in the immune/inflammatory related stress response soon after injury, low MLR level was associated with the worsening of disease condition.</p>","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140183582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive and Carcinogenic Roles of Necroptosis-Related miR-425-5p and miR-16-5p in Esophageal Squamous Cell Carcinoma. 与坏死相关的 miR-425-5p 和 miR-16-5p 在食管鳞状细胞癌中的预测作用和致癌作用
IF 0.8 4区 医学 Q3 Medicine Pub Date : 2024-01-01
Xue Zhidan, Xi Kedi, Xi Dan, Song Xing, Sun Rui

Objective: To examine the expression and function of necroptosis-associated miRNAs in esophageal squamous cell carcinoma.

Methods: A total of three microarray datasets, i.e., GSE122497, GSE114110, and GSE43732, were selected from the GEO database for differential analysis of necroptosis-related miRNA expression. The differentially expressed miRNAs were screened for target miRNAs using Kaplan-Meier survival analysis in the OncomiR database. The expression of the target miRNAs in the HEEC, KYSE-450, TE-1, and KYSE-410 cell lines was measured via qPCR. The expression of the target miRNAs in esophageal cancer cells was regulated by transfection with Lipofectamine 2000, and cell proliferation, cell migration, cell apoptosis and the cell cycle were detected by CCK-8, Transwell, and flow cytometry.

Results: The tumor tissue and peripheral blood of esophageal squamous cell cancer patients showed differential expression of 7 miRNAs related to necroptosis. Survival analysis revealed that miR-425-5p and miR-16-5p were negatively correlated with patient survival. The esophageal squamous cell carcinoma cell lines exhibited increased expression of miR-425-5p and miR-16-5p, with KYSE-410 exhibiting the most significant increase. Inhibition of miR-425-5p and miR-16-5p expression in the KYSE-410 cell line resulted in increased apoptosis, decreased proliferation, and decreased migration of esophageal cancer cells as well as a significant increase in the S phase and a decrease in the G2/M phase according to the cell cycle assay.

Conclusion: The pro-carcinogenic role of miR-425-5p and miR-16-5p has been observed in esophageal squamous cell carcinoma.

目的:研究食管鳞状细胞癌坏死相关 miRNA 的表达和功能:研究食管鳞状细胞癌坏死相关miRNA的表达和功能:从 GEO 数据库中选取 GSE122497、GSE114110 和 GSE43732 这三个芯片数据集,对坏死相关 miRNA 的表达进行差异分析。利用 OncomiR 数据库中的 Kaplan-Meier 生存分析,筛选出差异表达的 miRNAs 作为目标 miRNA。通过 qPCR 测定目标 miRNA 在 HEEC、KYSE-450、TE-1 和 KYSE-410 细胞系中的表达。用 Lipofectamine 2000 转染食管癌细胞,并用 CCK-8、Transwell 和流式细胞术检测细胞增殖、细胞迁移、细胞凋亡和细胞周期:结果表明:食管鳞癌患者的肿瘤组织和外周血中与坏死相关的7种miRNA的表达存在差异。生存率分析表明,miR-425-5p 和 miR-16-5p 与患者生存率呈负相关。食管鳞状细胞癌细胞系的 miR-425-5p 和 miR-16-5p 表达增加,其中 KYSE-410 的增加最为显著。抑制 miR-425-5p 和 miR-16-5p 在 KYSE-410 细胞系中的表达会导致食管癌细胞凋亡增加、增殖减少、迁移降低,并且根据细胞周期测定,S 期显著增加,G2/M 期减少:结论:在食管鳞状细胞癌中观察到了 miR-425-5p 和 miR-16-5p 的促癌作用。
{"title":"Predictive and Carcinogenic Roles of Necroptosis-Related miR-425-5p and miR-16-5p in Esophageal Squamous Cell Carcinoma.","authors":"Xue Zhidan, Xi Kedi, Xi Dan, Song Xing, Sun Rui","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To examine the expression and function of necroptosis-associated miRNAs in esophageal squamous cell carcinoma.</p><p><strong>Methods: </strong>A total of three microarray datasets, i.e., GSE122497, GSE114110, and GSE43732, were selected from the GEO database for differential analysis of necroptosis-related miRNA expression. The differentially expressed miRNAs were screened for target miRNAs using Kaplan-Meier survival analysis in the OncomiR database. The expression of the target miRNAs in the HEEC, KYSE-450, TE-1, and KYSE-410 cell lines was measured via qPCR. The expression of the target miRNAs in esophageal cancer cells was regulated by transfection with Lipofectamine 2000, and cell proliferation, cell migration, cell apoptosis and the cell cycle were detected by CCK-8, Transwell, and flow cytometry.</p><p><strong>Results: </strong>The tumor tissue and peripheral blood of esophageal squamous cell cancer patients showed differential expression of 7 miRNAs related to necroptosis. Survival analysis revealed that miR-425-5p and miR-16-5p were negatively correlated with patient survival. The esophageal squamous cell carcinoma cell lines exhibited increased expression of miR-425-5p and miR-16-5p, with KYSE-410 exhibiting the most significant increase. Inhibition of miR-425-5p and miR-16-5p expression in the KYSE-410 cell line resulted in increased apoptosis, decreased proliferation, and decreased migration of esophageal cancer cells as well as a significant increase in the S phase and a decrease in the G2/M phase according to the cell cycle assay.</p><p><strong>Conclusion: </strong>The pro-carcinogenic role of miR-425-5p and miR-16-5p has been observed in esophageal squamous cell carcinoma.</p>","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140183578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: Comparing the Novel Parameter 'Slope of the Steepest Part of Hemolysis Curve' to Standard Median Corpuscular Fragility for Evaluating Erythrocyte Stability during Prolonged Storage. 致编辑的信:比较新参数 "溶血曲线最陡峭部分的斜率 "与标准中位体细胞脆性,以评估红细胞在长期储存过程中的稳定性。
IF 0.8 4区 医学 Q3 Medicine Pub Date : 2024-01-01
Marijana Marković Boras, Kristina Kvesić, Stanislava Talić, Dragana Pušić

Objective: Several ways for presenting the results of osmotic fragility test have been described in the literature. Our aim was to compare the utility of a novel parameter for assessment of erythrocyte osmotic properties, i.e., 'Slope of the steepest part of hemolysis curve' with the most frequently used parameter 'Median corpuscular fragility' in order to assess the stability of erythrocytes in a blood sample during prolonged storage.

Methods: Ten whole blood samples were obtained from healthy donors. The osmotic fragility test was initially conducted on the day of venipuncture, and subsequent analyses were carried out on days 1, 2, 4, 7, 9, 11, and 14 after the venipuncture. Mean hemolysis percentage values were used to construct hemolysis curves. The steepest parts of hemolysis curves were estimated to be linear, and lines that overlapped those parts of the curves were created. The slope of these lines was calculated, and the resulting mean values are presented.

Results: A significant increase in Median corpuscular fragility values was observed, starting from day of venipuncture. We compared the average values for each day of analysis. The first significant difference in Median corpuscular fragility values was observed on day 4 compared to the day of venipuncture (p=0.006), with values 0.53±0.030 % and 0.41±0.014% respectively. Meanwhile, differences in the values of the slopes of the steepest parts of hemolysis curves were observed as early as day 2 when compared to the day of venipuncture (p=0.046), with values of -966.23±233.07 and -588.01±222.85, respectively.

Conclusion: Prolonged storage of whole blood samples leads to an increase in osmotic fragility and alters the shape of the hemolysis curve. These changes suggest that postponing the osmotic fragility test could lead to diagnostic inaccuracies. These findings suggest that slope value is a more accurate parameter for evaluating erythrocyte stability during storage, compared to commonly used Median corpuscular fragility value. Hence, it has potential importance and can be complementary to the laboratory result of the OFT. Therefore, it can be useful to provide these results jointly with the results of the OFT test.

目的:文献中描述了几种呈现渗透脆性测试结果的方法。我们的目的是比较用于评估红细胞渗透特性的新参数(即 "溶血曲线最陡部分的斜率")与最常用的参数 "中位血球脆性 "的实用性,以评估血液样本中的红细胞在长期储存过程中的稳定性:方法:从健康献血者处采集 10 份全血样本。渗透脆性测试最初在静脉穿刺当天进行,随后在静脉穿刺后的第 1、2、4、7、9、11 和 14 天进行分析。平均溶血百分比值用于构建溶血曲线。估计溶血曲线最陡峭的部分为线性,并绘制与这些部分重叠的直线。结果:结果:从静脉穿刺当天开始,中位血球脆性值明显增加。我们比较了每天分析的平均值。与静脉穿刺当天相比,第 4 天观察到中位体液脆性值首次出现明显差异(p=0.006),分别为 0.53±0.030 % 和 0.41±0.014%。同时,与静脉穿刺当天相比,溶血曲线最陡部分的斜率值早在第 2 天就出现了差异(p=0.046),分别为 -966.23±233.07 和 -588.01±222.85:结论:长时间储存全血样本会导致渗透脆性增加,并改变溶血曲线的形状。这些变化表明,推迟渗透脆性试验可能会导致诊断不准确。这些研究结果表明,与常用的中位红细胞脆性值相比,斜率值是评估红细胞在储存期间稳定性的更准确参数。因此,斜率值具有潜在的重要性,可作为 OFT 实验室结果的补充。因此,将这些结果与 OFT 检测结果一并提供会很有用。
{"title":"<i>Letter to the Editor:</i> Comparing the Novel Parameter 'Slope of the Steepest Part of Hemolysis Curve' to Standard Median Corpuscular Fragility for Evaluating Erythrocyte Stability during Prolonged Storage.","authors":"Marijana Marković Boras, Kristina Kvesić, Stanislava Talić, Dragana Pušić","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Several ways for presenting the results of osmotic fragility test have been described in the literature. Our aim was to compare the utility of a novel parameter for assessment of erythrocyte osmotic properties, i.e., 'Slope of the steepest part of hemolysis curve' with the most frequently used parameter 'Median corpuscular fragility' in order to assess the stability of erythrocytes in a blood sample during prolonged storage.</p><p><strong>Methods: </strong>Ten whole blood samples were obtained from healthy donors. The osmotic fragility test was initially conducted on the day of venipuncture, and subsequent analyses were carried out on days 1, 2, 4, 7, 9, 11, and 14 after the venipuncture. Mean hemolysis percentage values were used to construct hemolysis curves. The steepest parts of hemolysis curves were estimated to be linear, and lines that overlapped those parts of the curves were created. The slope of these lines was calculated, and the resulting mean values are presented.</p><p><strong>Results: </strong>A significant increase in Median corpuscular fragility values was observed, starting from day of venipuncture. We compared the average values for each day of analysis. The first significant difference in Median corpuscular fragility values was observed on day 4 compared to the day of venipuncture (<i>p</i>=0.006), with values 0.53±0.030 % and 0.41±0.014% respectively. Meanwhile, differences in the values of the slopes of the steepest parts of hemolysis curves were observed as early as day 2 when compared to the day of venipuncture (<i>p</i>=0.046), with values of -966.23±233.07 and -588.01±222.85, respectively.</p><p><strong>Conclusion: </strong>Prolonged storage of whole blood samples leads to an increase in osmotic fragility and alters the shape of the hemolysis curve. These changes suggest that postponing the osmotic fragility test could lead to diagnostic inaccuracies. These findings suggest that slope value is a more accurate parameter for evaluating erythrocyte stability during storage, compared to commonly used Median corpuscular fragility value. Hence, it has potential importance and can be complementary to the laboratory result of the OFT. Therefore, it can be useful to provide these results jointly with the results of the OFT test.</p>","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":null,"pages":null},"PeriodicalIF":0.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140183566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of clinical and laboratory science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1